EF Hutton Initiates Coverage On Immunic With Buy Rating, Announces Price Target of $17
EF Hutton Initiates Coverage On Immunic With Buy Rating, Announces Price Target of $17
EF Hutton發起對immunic的買入評級，宣佈目標股價爲17美元
EF Hutton analyst Jason Kolbert initiates coverage on Immunic (NASDAQ:IMUX) with a Buy rating and announces Price Target of $17.
EF Hutton分析師Jason Kolbert以買入評級啓動對Immunic（NASDAQ:IMUX）的覆蓋，並宣佈目標價格爲$17。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間